Jul. 1 at 3:03 AM
$QNRX if I had to call out one potential issue, it’s the topline potentially slipping to q1 2027…tight runway, cash burn will only accelerate with p3 underway…a capital raise is a near certainty. the question is whether Dr. Myers can leverage his business savvy to raise on favorable terms…he’s smart I think, let’s wait it out…for an ultra rare disease and high unmet need, it has multiple ODDs + fast track, established brand, Japan infrastructure already in place…. better positioned than most micro caps…an ounce of good news and its cap will dramatically increase.. 🐋
